The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on October 12, 2026

2 hours ago

Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma

Indeterminate GlobeNewswire

2 hours ago

Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies

Indeterminate GlobeNewswire

2 hours ago

Beacon Therapeutics Presents Data from Pivotal VISTA Trial of Laru-zova at AAO 2026

Indeterminate GlobeNewswire

2 hours ago

First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease

Indeterminate GlobeNewswire

2 hours ago

Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting

Indeterminate GlobeNewswire

3 hours ago

Gates Foundation and Wellcome Leap Commit $100 Million to Reduce Global Stillbirth Rates

Indeterminate GlobeNewswire

3 hours ago

MediciNova CEO Provides Shareholder Update

Indeterminate GlobeNewswire

5 hours ago

Concept Life Sciences Appoints Dr Adrijana Vinter as Chief Executive Officer

Indeterminate GlobeNewswire

8 hours ago

Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity

Indeterminate GlobeNewswire

11 hours ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer

Indeterminate GlobeNewswire

13 hours ago

InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China

Indeterminate GlobeNewswire